Option Care Health Inc. (NASDAQ:OPCH) agreed Tuesday to be taken private by Clayton Dubilier & Rice and McKesson Corp. (NYSE:MCK) for $32.05 a share in cash. The deal gives the home-infusion provider a total enterprise value of about $5.8 billion.

Private equity firm CD&R and McKesson Corporation (NYSE:MCK) on Tuesday agreed to acquire Option Care Health Inc. (NASDAQ:OPCH) for $32.05 per share.

Mckesson Corp (NYSE:MCK), the US healthcare services and drug distribution company, and Clayton Dubilier & Rice (CD&R), the private investment firm, have agreed to acquire Option Care Health (NASDAQ:OPCH) for approximately $5.8 billion. The buyers will pay $32.05 a share for Option Care Health, the largest independent provider of home and alternate-site infusion services in the US, representing a 37% premium to Monday's closing price.

Under the agreement, CD&R will hold a majority interest of about 51% in Option Care Health, while McKesson will hold about 49%.

What happened McKesson Corporation (NYSE: MCK) said on October 6, 2026, it signed a definitive agreement with Clayton, Dubilier Rice, LLC and Option Care Health, Inc. CD R will hold about 51% of Option Care Health and McKesson will invest about $1.4 billion for a minority interest of about 49%. The deal values Option Care

NEW YORK & IRVING, Texas & BANNOCKBURN, Ill.--(BUSINESS WIRE)--CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. At the closing of.

Park National Corp OH lowered its stake in shares of McKesson Corporation (NYSE: MCK) by 8.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,304 shares of the company's stock after selling 1,183 shares during the quarter. Park

The arrangement is now in force through June 2032. McKesson also reaffirmed its guidance for the current fiscal year.

Bond yields hit their highest level in two decades, pressuring blue chip dividend stocks and weighing on the broader market, today, Oct. 1, 2026.

Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.